PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0002 (40.00%)
At close: Sep 8, 2026
PaxMedica Market Cap
PaxMedica has a market cap or net worth of $88.39 thousand as of September 8, 2026. Its market cap has increased by 250.59% in one year.
Market Cap
88.39K
Enterprise Value
-356.46K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since August 26, 2022, PaxMedica's market cap has decreased from 49.18M to 88.39K, a decrease of -99.82%. That is a compound annual growth rate of -79.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 88.39K | 600.09% |
| Dec 31, 2025 | 12.63K | -98.19% |
| Dec 31, 2024 | 697.96K | -79.65% |
| Dec 29, 2023 | 3.43M | -85.66% |
| Dec 30, 2022 | 23.91M | -51.38% |
| Aug 26, 2022 | 49.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| ProtoKinetix | 82.33K |
| Sigyn Therapeutics | 73.75K |
| Vincerx Pharma | 68.57K |
| Scorpius Holdings | 67.26K |
| U.S. Stem Cell | 66.15K |
| Nascent Biotech | 51.85K |